Search the Newsreel

Ohio Valley Banc Corp (OVBC) director adds shares through cash-funded DRIP purchases

Ohio Valley Banc Corp (OVBC) director Michael Seth Isaac reported acquiring 71.6936 common shares on August 12, 2026, through cash-funded dividend reinvestment plan (DRIP) purchases. He bought 67.4321 shares at $44.4892 each and received an additional 4.2615 shares via DRIP, bringing his direct holdings …

Ohio Valley Banc director Anna Barnitz buys $1,500 in shares

Ohio Valley Banc Corp. director Anna Barnitz recently purchased $1,500 worth of common shares through a dividend reinvestment plan. This transaction, involving 33.7161 shares at $44.4892 each, increased her direct holdings to over 9,000 shares, alongside indirect holdings for her sons. The bank has …

AvalonBay Communities (NYSE: AVB) holders approve merger and 2.793‑for‑1 share exchange

AvalonBay Communities stockholders overwhelmingly approved the proposed merger of equals with Equity Residential, along with merger-related compensation and an adjournment proposal, at a special meeting on August 12, 2026. The merger is expected to close on August 17, 2026, with each AvalonBay share converting …

Equity Residential, AvalonBay shareholders approve merger (EQR:NYSE)

Shareholders of AvalonBay Communities (AVB) and Equity Residential (EQR) have approved all proposals for their pending merger of equals. The announcement was made after separate special meetings held by each multifamily REIT.

Equity Residential and AvalonBay Communities Announce Shareholder Approvals for Merger to Create Vivmark Residential

Equity Residential and AvalonBay Communities announced that shareholders of both companies have overwhelmingly approved the merger to create Vivmark Residential. The merger is expected to close on Monday, August 17, 2026, and the combined company's shares will trade under the ticker symbol "VMRK" on …

Avalo Therapeutics (AVTX) CSO Riley sells 2,655 shares at about $19.59

Avalo Therapeutics' Chief Strategy Officer, Jennifer Riley, sold 2,655 shares of common stock on August 11, 2026, at a weighted average price of $19.5903 per share. The transactions occurred within a price range of $19.54 to $19.65. Following this sale, Riley directly holds 37,041 …

Avalo Therapeutics (AVTX) CMO Mittie Doyle exercises options and sells 679 shares

Avalo Therapeutics (AVTX) Chief Medical Officer Mittie Doyle exercised options for 679 shares at $8.04 per share and subsequently sold the same number of shares at $20.00 per share on August 10, 2026. These transactions were executed under a pre-established Rule 10b5-1 trading plan. …

Valens Semiconductor Q2 Earnings Call Highlights

Valens Semiconductor (NYSE: VLN) surpassed its Q2 expectations with $18.1 million in revenue, driven by strong performance in its audio/video business. The company raised its full-year 2026 revenue guidance to $78 million–$81 million, indicating approximately 13% growth. While automotive revenue saw a sequential decline …

Valens Semiconductor (NYSE:VLN) Issues Earnings Results, Meets Estimates

AQR entities (SVAQ) disclose 5.05% beneficial stake in Silicon Valley Acquisition

AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, and AQR Arbitrage, LLC have jointly reported a 5.05% beneficial ownership stake in Silicon Valley Acquisition Corp.'s Class A ordinary shares. This equates to 1,119,068 shares, over which the AQR entities have shared voting and …

Valvoline (VVV) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Investor Relations - Elizabeth ClevingerPresident and Chief Executive Officer - Lori FleesChief Financial Officer - Kevin Willis TAKEAWAYS Net Revenues -- Rose 24% to $544.6 million, reflecting core …

Vale, ABB to partner for more AI, automation solutions at iron ore processing plants (VALE:NYSE)

Vale and ABB have signed an agreement to expand the use of automation and artificial intelligence technologies in Vale's iron ore processing plants. This partnership aims to enhance safety and productivity in the mining operations. This collaboration follows a prior agreement between the two …

Savers Value Village (NYSE:SVV) Shares Gap Down - Here's Why

Savers Value Village (NYSE:SVV) shares gapped down by 9.7% to $10.99, despite their latest quarterly results generally meeting expectations. The company reported EPS of $0.14 and revenue of $448.22 million, with sales up 7.4% year-over-year. The drop occurred amid mixed analyst sentiment, with a …

Valor Gold Corp Stock Surges 4.77% as Trading Activity Spikes and Market Attention Builds

Valion Bio Inc. (VBIO) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength

This article provides a company profile for Valion Bio Inc. (VBIO), detailing its operations as a bio-electronic health-tech company developing micro current therapy solutions. It includes key financial facts such as market capitalization, 52-week high and low prices, current and previous day's stock prices, …

Valens Semiconductor Ltd. Q2 2026 Earnings Call Summary

Valens Semiconductor Ltd. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Revenue …

Valero Energy Corp. stock outperforms competitors on strong trading day

Valero Energy Corp. (VLO) saw its stock rise by 1.94% to $330.21 on Wednesday, marking its third consecutive day of gains. This performance occurred during a mixed trading session where the S&P 500 Index increased by 0.26%, while the Dow Jones Industrial Average fell …

Valens Semiconductor Releases Q2 2026 Financial Results

Valens Semiconductor (VLN) reported Q2 2026 financial results, with a Non-GAAP loss per share of $0.04, matching estimates. Revenue reached $18.1M, a 6% year-over-year increase, driven primarily by its Cross-Industry Business (CIB). The company provided revenue guidance for the next quarter between $21.3M and …

Why Valor Gold Corp. stock is rising today

Grupo Aval Acciones y Valores SA Sponsored ADR Pfd Financial Disclosures & SEC Filings

This article provides a comprehensive list of financial disclosures and SEC filings for Grupo Aval Acciones y Valores S.A. (AVAL) from 2023 to 2026. It highlights key earnings reports, including details on net income, ROAE, loan growth, and capital ratios for various quarters. The …

Valion Bio begins safety study for radiation injury drug By Investing.com

Valion Bio Inc. (NASDAQ:VBIO) is commencing a safety study for its drug Entolimod, aimed at treating radiation-induced gastrointestinal injury. The study, funded by a government program, will confirm the drug's tolerability in animals, with a therapeutic study to follow and top-line data expected in …

Grupo Aval Acciones y Valores (NYSE:AVAL) Upgraded at JPMorgan Chase & Co.

JPMorgan Chase & Co. has upgraded Grupo Aval Acciones y Valores (NYSE:AVAL) from an "underweight" to a "neutral" rating, setting a $5.50 price target. This upgrade implies a potential 4.86% upside from the previous closing price, aligning with the overall neutral sentiment from analysts, …

Savers Value Village Plans $10M Buyback Alongside Stock Sale

Savers Value Village, Inc. (NYSE: SVV) announced a proposed secondary public offering of 15,000,000 shares by certain Ares Private Equity funds. Concurrently, the company plans to repurchase $10 million of common stock from the underwriters using existing cash. The company itself is not selling …

Valero Energy Corporation (VLO) Hit a 52 Week High, Can the Run Continue?

Have you been paying attention to shares of Valero Energy (VLO)? Shares have been on the move with the stock up 7.5% over the past month. The stock hit a new 52-week high of $324.38 in the previous session. Valero Energy has gained 99% …

Valiant Organics Q1FY26 net profit jumps 188% to ₹29.26 crore

Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury

Valion Bio announced that the U.S. government is funding studies through AFRRI/NIAID to evaluate Entolimod for radiation-induced gastrointestinal (GI) injury. These studies, including a safety study starting this week and a therapeutic study to follow, aim to determine Entolimod's effectiveness in supporting survival and …

Valion Bio Plans Mouse Study After Lethal Radiation Exposure

Valion Bio (Nasdaq: VBIO) announced that the U.S. government-funded Armed Forces Radiobiology Research Institute (AFRRI) program, under a NIAID contract, will begin evaluating Entolimod for lethal radiation-induced gastrointestinal (GI) injury. A safety study is set to start this week, followed by a therapeutic study …

Avalyn: Q2 Earnings Snapshot

Valiant Organics consolidated net profit rises 254.27% in the June 2026 quarter

Avalyn Pharma Inc. Q2 2026: Net loss $(28.9M), EPS $(0.98) — 10-Q Summary

Avalyn Pharma Inc. reported a wider net loss of $(28.9M) in Q2 2026, compared to $(20.2M) in Q2 2025, with basic and diluted net loss per share at $(0.98). The clinical-stage biotech company continues to invest in its development programs, including AP01, AP02, and …

Avalyn Pharma reports Q2 2026 net loss $28.9M; cash $413.5M, runway into 2029

Avalyn Pharma reported a Q2 2026 net loss of $28.9 million, ending the period with $413.5 million in cash, which is projected to fund operations into 2029. The company saw increased R&D and G&A expenses due to clinical activity and headcount. Key business highlights …

Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com

This article reports that Avalyn Pharma Inc. has filed a Form 8K for August 12, as reported by Investing.com. The filing is brief and does not provide further details within the article content. It is categorized under stock market news.

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Avalyn Pharma Inc. announced its financial results for the second quarter ended June 30, 2026, and highlighted recent business achievements, including the completion of enrollment for its MIST global Phase 2b trial of AP01 with 398 patients. The company reported $413.5 million in cash, …

Valens Semiconductor, Ltd. (VLN) Reports Q2 Loss, Beats Revenue Estimates

Valens Semiconductor, Ltd. (VLN) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it …

Valley National Bancorp $VLY Shares Sold by Wedge Capital Management L L P NC

Are Wall Street Analysts Bullish on Valero Energy Stock?

The logo of Valero Energy on the screen of an exchange_ By maurice norbert Valero Energy Corporation (VLO), headquartered in San Antonio, Texas, manufactures, markets, and distributes petroleum-based and low-carbon liquid transportation fuels and petrochemical products. Valued at $90.7 billion by market cap, the …